Lucet Appoints Dr. Sean Martin as Chief Medical Officer to Accelerate Vision for Integrated, Whole-Person Behavioral Health Care Lucet, a pioneering force in the behavioral health landscape, has announced the appointment of Dr. Sean Martin as its new Chief Medical…
Comprehensive Market Report Highlights Transformative Role of Mesenchymal Stem Cells Across Therapeutics, Cosmetics, and Cultured Meat Industries A newly published strategic intelligence report titled “Mesenchymal Stem Cells/Medicinal Signaling Cells (MSCs) – Advances & Applications, 2025” has been added to the…
Community Health Systems, Inc. Announces Details for Third Quarter 2025 Earnings Conference Call and Webcast Community Health Systems, Inc. (NYSE: CYH), one of the nation’s leading operators of general acute care hospitals and a prominent provider of healthcare services across…
AndHealth Neurology Welcomes Dr. Ken Mankowski as Director of Its Neuroscience Center of Excellence AndHealth Neurology has announced the appointment of Dr. Ken Mankowski as the new Director of its Neuroscience Center of Excellence, strengthening its leadership and clinical expertise…
KeyBank Partners with MediStreams to Strengthen Healthcare Payment Management and Revenue Cycle Efficiency KeyBank has announced a strategic collaboration with MediStreams, a leading provider of payment and remittance automation solutions, to power its new Healthcare Payment Management Platform. This partnership…
AleraCare Appoints Joseph Cosgrove as CEO and Board Member Amid Pivotal Merger with PURE Healthcare AleraCare, a nationally recognized provider of infusion and specialty pharmacy services, has officially announced the appointment of Joseph Cosgrove as its new Chief Executive Officer…
Axena Health Joins AARP Accelerator’s AgeTech Collaborative™ to Advance Women’s Pelvic Health Innovations Axena Health, Inc. (Axena Health), a leading medical device company dedicated to redefining the standard of care for women’s pelvic health, has announced its selection to participate…
Emalex Biosciences’ Expanded Access Program for Investigational Tourette Syndrome Therapy Receives FDA Authorization Emalex Biosciences, a clinical-stage biopharmaceutical company focused on developing innovative treatments for neurodevelopmental and neurological disorders, today announced a major development in its Tourette syndrome (TS) program.…
Groundbreaking ABRAT™-H Study Demonstrates Significant Reduction in Hospitalized Patient Violence, Reinforcing Efficacy of Proactive Risk Assessment Tools A landmark interventional study—the ABRAT™-H (Aggressive Behavior Risk Assessment Tool for Hospitalized Patients)—has yielded compelling evidence that structured screening combined with targeted interventions…
Liberty Dental Plan of Florida Launches Comprehensive Week of Service to Expand Access to Free Dental Care and Oral Health Education In a bold and compassionate initiative aimed at addressing critical gaps in oral health access across the Sunshine State,…
HealthStream Strengthens Payer-Focused Credentialing Capabilities with Strategic Acquisition of Virsys12 HealthStream (Nasdaq: HSTM), a nationally recognized leader in healthcare workforce development and technology solutions, has announced the strategic acquisition of Virsys12, a prominent healthcare technology company specializing in provider data…
GoodRx to Announce Third Quarter 2025 Financial Results on November 4, 2025, with Conference Call Scheduled for November 5, 2025 GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-centric digital healthcare platform known for helping millions of Americans access affordable medications,…